Plaintiffs Seek Appointment of Leadership in Ozempic MDL
April 8, 2024
DOCUMENTS
- Motion
- Opposition
PHILADELPHIA — Plaintiffs in the MDL for cases alleging injuries caused by glucagon-like peptide-1 receptor agonists (GLP-1RAs) have filed an amended motion for appointment of leadership, arguing the “proposed co-lead counsel have already undertaken significant efforts to advance this litigation over the past seven months, and readily satisfy all potentially applicable criteria for appointment.”
Proposed co-lead counsel are Parvin Aminolroaya of Seeger Weiss, LLP, Sarah Ruane of Wagstaff & Cartmell LLP, Jonathan D. Orent of Motley Rice, LLC and Paul Pennock of Morgan & Morgan P.A. Proposed liaison counsel are Roberta Liebenbeg of Fine Kaplan & Black R.P.C. and Nina …
UPCOMING CONFERENCES
![](https://harrismartin.s3.amazonaws.com/media/CACHE/images/uploads/conferences/iStock-1194111238/676070b74c476caea791c965bb161cef.jpg)
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
October 25, 2024 - Long Beach, CA
The Westin Long Beach
![](https://harrismartin.s3.amazonaws.com/media/CACHE/images/uploads/conferences/iStock-115753557_fLooJhx/ebadaa70c9ae4eba2f27c08bcd68c09c.jpg)
HarrisMartin's Midwest Asbestos Litigation Conference
September 27, 2024 - St. Louis, MO
Four Seasons Hotel, St. Louis